SCHEMBL29469855

SCHEMBL29469855

Cc1cc(S(=O)(=O)NC(=O)c2cc3c(F)cc(N4CCC4)cc3o2)c2ncccc2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GFER P55789 1/20 0.37
FABP1 P07148 1/20 0.36
KMT2A Q03164 2/20 0.36
LDHA P00338 1/20 0.36
HCRTR1 O43613 1/20 0.36
ALDH1A1 P00352 3/20 0.35
TMEM97 Q5BJF2 1/20 0.35
SIGMAR1 Q99720 1/20 0.35
SLC16A3 O15427 1/20 0.35
TSHR P16473 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
COMT P21964 1/20 0.34
MAPK1 P28482 1/20 0.34
CNR2 P34972 1/20 0.34
SLC40A1 Q9NP59 1/20 0.34
PKLR P30613 3/20 0.34
GAA P10253 1/20 0.33
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24333797 1.00 GFER (0.37) GFERFABP1KMT2ALDHAHCRTR1
SCHEMBL24333372 0.87 DCTPP1 (0.37) GFERFABP1KMT2ALDHAALDH1A1
SCHEMBL29469870 0.87 DCTPP1 (0.37) GFERFABP1KMT2ALDHAALDH1A1
SCHEMBL29469919 0.85 CNR2 (0.37) GFERFABP1KMT2ALDHAALDH1A1
SCHEMBL29469675 0.83 MAPT (0.39) KMT2AALDH1A1NPC1RAB9AMAPK1
SCHEMBL24334259 0.83 MAPT (0.39) KMT2AALDH1A1NPC1RAB9AMAPK1
SCHEMBL24334001 0.82 POLB (0.42) GFERFABP1KMT2ALDHAALDH1A1
SCHEMBL29469820 0.82 POLB (0.42) GFERFABP1KMT2ALDHAALDH1A1
SCHEMBL29469666 0.82 ALDH1A1 (0.36) KMT2AALDH1A1MAPK1SLC40A1GAA
SCHEMBL24334212 0.82 CCKBR (0.42) GFERPKLR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4229048-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute, Inc. (US) 2023-08-23 EP disclosed
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed